LPAAT-β inhibitors and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7608620
APP PUB NO 20070072856A1
SERIAL NO

11601513

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to triazines and the use thereof to inhibit lysophosphatidic acid acyltransferase β (LPAAT-β) activity. The invention further relates to methods of treating cancer using said triazines. The invention also relates to methods for screening for LPAAT-β activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CELL THERAPEUTICS INCSEATTLE WA 98121

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bonham, Lynn Seattle , US 8 7
Finney, Robert E Shoreline , US 15 76
Gong, Baoqing Shoreline , US 30 147
Hollenback, David M Seattle , US 8 6
Klein, J Peter Vashon , US 67 842
Leung, David W Mercer Island , US 36 662
Shaffer, Scott A Seattle , US 10 299
Tang, Norina M Ann Arbor , US 7 6
Tulinsky, John Seattle , US 18 139
White, Thayer H Bellevue , US 7 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation